000 01647 a2200457 4500
005 20250515153534.0
264 0 _c20090326
008 200903s 0 0 eng d
022 _a1096-8652
024 7 _a10.1002/ajh.21340
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDíez-Campelo, María
245 0 0 _aMinimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies.
_h[electronic resource]
260 _bAmerican journal of hematology
_cMar 2009
300 _a149-52 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCohort Studies
650 0 4 _aFlow Cytometry
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xpathology
650 0 4 _aMiddle Aged
650 0 4 _aMyelodysplastic Syndromes
_xpathology
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm, Residual
_xpathology
650 0 4 _aPredictive Value of Tests
650 0 4 _aSurvival Analysis
650 0 4 _aTransplantation, Homologous
650 0 4 _aYoung Adult
700 1 _aPérez-Simón, José Antonio
700 1 _aPérez, Jose
700 1 _aAlcoceba, Miguel
700 1 _aRichtmon, Juan
700 1 _aVidriales, Belén
700 1 _aSan Miguel, Jesús
773 0 _tAmerican journal of hematology
_gvol. 84
_gno. 3
_gp. 149-52
856 4 0 _uhttps://doi.org/10.1002/ajh.21340
_zAvailable from publisher's website
999 _c18572986
_d18572986